← Eichor
Study identifier: NCT06983028 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Atacicept in Multiple Glomerular Diseases

Condition: pMN · IgAN · Nephrotic Syndrome  ·  Sponsor: Vera Therapeutics, Inc.

PhasePhase 2
Planned participants250
Who can joinAll sexes, 2 Years to no upper limit
Healthy volunteersNo

About this study

A study to find how well atacicept works and how safe it is in participants with autoimmune kidney disease.

This description comes directly from the study's public registry record.

Talk to the study team

Vera Therapeutics, Inc. Clinical Trials Information  ·  650-770-0077  ·  PIONEERStudy@veratx.com

Always discuss trial participation with your own doctor first.

Locations (1)

Vera TherapeuticsBrisbane, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06983028